With the rapid development of stem cell technology and gene therapy in the field of medicine, its application prospects in the treatment of blinding eye diseases are becoming increasingly broad. In order to strengthen academic exchanges among domestic peers in the field of stem cell and gene therapy blinding eye diseases, display the latest research results, discuss technical problems and hot issues, and improve the treatment level of blinding eye diseases, the "Academic Seminar on Stem Cell and Gene Therapy of Blind Eye Diseases" sponsored by the Chongqing Anatomy Society and co-organized by Jinfeng Laboratory and the First Affiliated Hospital of the Army Military Medical University is scheduled to be held in Chongqing from June 27 to 28, 2025.

The purpose of this conference is to build a high-end academic exchange platform, inviting well-known domestic ophthalmologists, scholars and industry elites to share the latest research results in the field of stem cell and gene therapy blinding eye diseases, new therapies, new technologies and future development trends, promote the innovation and application of ophthalmic medical technology, and promote the comprehensive development of ophthalmic science. The details of the meeting are as follows: